Secretion of soluble ST2 - Possible explanation for systemic immunosuppression after heart surgery

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 1, 2009, Pages 25-29

  Szerafin, T ^a   Niederpold, T ^b   Mangold, A ^b   Hoetzenecker, K ^b   Hacker, S ^b   Roth, G ^b   Lichtenauer, M ^b   Dworschak, M ^b   Wolner, E ^b   Ankersmit, H J ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

CABG; Immunology; Inflammation

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; SOLUBLE ST2 RECEPTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CYTOKINE; IL1RL1 PROTEIN, HUMAN; IMMUNOGLOBULIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; BLOOD; CARDIOPULMONARY BYPASS; CORONARY ARTERY DISEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MIDDLE AGED; TIME; UPREGULATION;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; TH1 CELLS; TH2 CELLS; TIME FACTORS; UP-REGULATION;

EID: 62449245589     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-2008-1039044     Document Type: Article

References (20)

1. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987;13:89-95
2. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaest 1995;75:724-733
3. Struber M, Cremer JT, Gohrbandt B et al. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 1999;68:1330-1335
4. Szerafin T, Brunner M, Horvath A et al. Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions. Clin Lab 2005;51:657-663
5. Szerafin T, Hoetzenecker K, Hacker S et al. Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg 2008;85:80-87
6. Szerafin T, Horvath A, Brunner M et al. Apoptosis-specific activation markers in on-versus off-pump coronary artery bypass graft (CABG) patients. Clin Lab 2006;52:255-261
7. Franke A, Lante W, Kurig E, Zoller LG, Weinhold C, Markewitz A. Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis? Ann Thorac Surg 2006;82:103-109
8. Franke A, Lante W, Markewitz A, Weinhold C. In vitro restoration of post-operatively decreased IFN-gamma levels after cardiac surgery and its effect on pro-and anti-inflammatory mediators. J Surg Res 2006;136:266-272
9. Friedman ND, Russo PL, Bull AL, Richards MJ, Kelly H. Validation of coronary artery bypass graft surgical site infection surveillance data from a statewide surveillance system in Australia. Infect Control Hosp Epidemiol 2007;28:812-817
10. Kuroiwa K, Arai T, Okazaki H, Minota S, Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Comm 2001;284:1104-1108
11. Lohning M, Stroehmann A, Coyle AJ et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998;95:6930-6935
12. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999;11:13-18
13. Granowitz EV, Porat R, Mier JW et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 1993;151:1637-1645
14. Nomura F, Akashi S, Sakao Y et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000;164:3476-3479
15. Brint EK, Xu D, Liu H et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004;5:373-379
16. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem Biophys Res Commun 2002;299:18-24
17. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007;282:26369-26380
18. Sweet MJ, Leung BP, Kang D et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001;166:6633-6639
19. Takezako N, Hayakawa M, Hayakawa H et al. ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 2006;341:425-432
20. Hoetzenecker K, Hacker S, Hoetzenecker W et al. Cytomegalovirus hyperimmunoglobulin: mechanisms in allo-immune response in vitro. Eur J Clin Invest 2007;37:978-986